Volume 60, Issue 6, Pages 2385-2391 (December 2001) The interleukin-10 promoter genotype determines clinical immune function in hemodialysis patients Matthias Girndt, Urban Sester, Martina Sester, Erik Deman, Christof Ulrich, Harald Kaul, Prof. Dr. Hans Köhler Kidney International Volume 60, Issue 6, Pages 2385-2391 (December 2001) DOI: 10.1046/j.1523-1755.2001.00062.x Copyright © 2001 International Society of Nephrology Terms and Conditions
Figure 1 Secretion of interleukin-10 (IL-10) by peripheral blood mononuclear cells (PBMC) from dialysis patients with different IL-10 genotypes after incubation without stimuli (A) or with monocyte directed (LPS, B) or lymphocyte directed (PHA, C, or anti-CD3, D) stimuli. Only results for stimulation by LPS were significantly different between both groups (P < 0.05). Kidney International 2001 60, 2385-2391DOI: (10.1046/j.1523-1755.2001.00062.x) Copyright © 2001 International Society of Nephrology Terms and Conditions
Figure 2 Production of IL-6 by PBMC from dialysis patients with different IL-10 genotypes after stimulation with LPS. The results were not significantly different (P = 0.07). Kidney International 2001 60, 2385-2391DOI: (10.1046/j.1523-1755.2001.00062.x) Copyright © 2001 International Society of Nephrology Terms and Conditions